Evidence map›Paper›PMID 36056546›Full record

ArticleJournal of neuroendocrinology2022

Time of day influences stress hormone response to ketamine.

Matthew T Birnie, Alen V Eapen, Yvonne M Kershaw, David Lodge, Graham L Collingridge, Becky L Conway-Campbell, Stafford L Lightman

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Circadian regulation of hippocampal function is disrupted with corticosteroid treatment.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Matthew T BirnieHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.ORCID 0000-0003-3964-5247
Alen V EapenHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.
Yvonne M KershawHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.ORCID 0000-0001-7318-2050
David LodgeSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK.
Graham L CollingridgeHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.ORCID 0000-0002-9572-5359
Becky L Conway-CampbellHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.ORCID 0000-0002-8494-7431
Stafford L LightmanHenry Wellcome Laboratories for Integrative Neuroendocrinology, School of Medicine, University of Bristol, Bristol, UK.ORCID 0000-0002-8546-9646
University of Bristol · GB

Funding

Medical Research Council MR/R010919/1Wellcome TrustWellcome Trust 089647/Z/09/Z
6 · The paper itself

Abstract

Over 50% of depressed patients show hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. Conventional therapy takes weeks to months to improve symptoms. Ketamine has rapid onset antidepressant effects. Yet its action on HPA axis activity is poorly understood. Here, we measured the corticosterone (CORT) response to ketamine administered at different times of day in the Wistar-Kyoto (WKY) rat. In male rats, blood was collected every 10 min for 28 h using an automated blood sampling system. Ketamine (5/10/25 mg · kg) was infused through a subcutaneous cannula at two time points-during the active and inactive period. CORT levels in blood were measured in response to ketamine using a radioimmunoassay. WKY rats displayed robust circadian secretion of corticosterone and was not overly different to Sprague Dawley rats. Ketamine (all doses) significantly increased CORT response at both infusion times. However, a dose dependent effect and marked increase over baseline was observed when ketamine was administered during the inactive phase. Ketamine has a robust and rapid effect on HPA axis function. The timing of ketamine injection may prove crucial for glucocorticoid-mediated action in depression.

Indexed as

KetaminePituitary-Adrenal SystemAnimalsCorticosteroneCorticotropin-Releasing HormoneHypothalamo-Hypophyseal SystemMaleRatsRats, Inbred WKYRats, Sprague-DawleyCorticosteroneCorticotropin-Releasing HormoneKetaminecircadiancortisol/corticosteroneglucocorticoidsketamine

Identifiers

PMID36056546
PMCPMC9787621
OpenAlexW4290342828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.